"biopharmaceutical"

The Centre will take shape by the end of the third quarter this year. This is part of the company's plans to expand its drug development and IT and digital innovation capabilities.

State to attract not just manufacturing facilities, but also R&D wings of leading pharmaceutical and medical devices companies